PerpEquities

Abivax S.A. (ABVX) balance sheet

NASDAQ · Healthcare · Biotechnology · 80 employees · CEO Marc de Garidel

Price
$86.59 -2.77%
Market cap
$7.58B
Enterprise value
€6.41B
Last report
Q2 '26 filed 2026-09-21
Next report
2026-12-21

At the end of Q2 '26 Abivax S.A. (ABVX) held €411M in cash and short-term investments against €1.21M of debt incl. leases. Total assets €462M, total liabilities €95.9M, shareholders' equity €366M.

Balance sheet

Balance sheetTrendQ4 '20Q2 '21Q4 '21Q2 '22Q4 '22Q2 '23Q4 '23Q2 '24Q4 '24Q2 '25Q4 '25Q2 '26
Assets
Cash & equivalents€29.3M€4.34M€60.7M€11.6M€27M€114M€252M€222M€144M€60.9M€516M€388M
Short-term investments€6K€6K€6K€15M€0€0€9.05M€0€0€0€0€22.7M
Receivables€8.04M€12.7M€8.34M€11M€8.32M€12.7M€19.1M€17.5M€15.7M€14.7M€10.5M€12.4M
Inventory€0€0€4M€0€0€0€0€0€0€0€0€0
Other current assets€1K€0€0€0€0€0-€1K€17.7M€0€70K€68.3M€125K
Current assets€37.7M€21.4M€75.2M€43.8M€36.2M€130M€286M€243M€171M€86.1M€619M€428M
Property, plant & equipment (net)€100K€79K€93K€113K€1.59M€202K€877K€2.57M€2.67M€2.16M€2.09M€1.52M
Long-term investments€215K€1.53M€214K€3.82M€0€56K€124K€0€126K€126K€126K€0
Goodwill€32M€32M€32.7M€32.7M€18.4M€18.4M€18.4M€18.4M€18.4M€18.4M€18.4M€18.4M
Intangible assets€98K€96K-€647K-€11.6M€6.61M€6.61M€6.6M€6.61M€6.61M€6.61M€6.6M€6.61M
Other non-current assets€1.21M€6K€2.75M€2.73M€12.7M€15.4M€15.1M€13.9M€6.74M€6.23M€5.53M€8.04M
Non-current assets€33.6M€33.7M€35.2M€27.8M€39.4M€40.7M€41.1M€41.5M€34.6M€33.5M€32.8M€34.6M
Total assets€71.3M€55.1M€109M€71.6M€75.5M€171M€327M€284M€205M€120M€652M€462M
Liabilities
Accounts payable€17.4M€18.9M€18.6M€14.5M€15.5M€15.3M€47.2M€30.6M€43.8M€36.1M€37.6M€18.3M
Accrued expenses€0€0€1.5M€628K€655K€14.1M€0€5.64M€0€21.4M€15.7M€20.7M
Short-term debt€12K€26.8M€10.1M€14K€29.5M€9.11M€30.9M€37.6M€42.8M€47.9M€28.5M€0
Taxes payable€231K€2M€88K€1.56M€86K€58K€2.38M€0€4.71M€0€0€177K
Deferred revenue€0€0€162K€0€133K€121K€52K€0€0€0€0€0
Other current liabilities€0€23.7M-€385K€829K€2.87M€4.58M€3.51M€5.67M€532K€3.67M-€11M€28.6M
Current liabilities€19.4M€47.7M€32.3M€16.7M€51.5M€46.2M€88.1M€80M€92.8M€112M€78.8M€71.7M
Long-term debt€34M€5M€40.3M€48.8M€8.29M€24.5M€26.6M€73.6M€52.2M€34.8M€15.9M€0
Lease obligations (non-current)€0€0€43K€0€839K€566K€160K€1.68M€1.43M€947K€554K€137K
Other non-current liabilities€9K€32K€10.4M€65K€7.77M€19.4M€16.2M€2.8M€18.2M€19.8M€45.6M€24.1M
Non-current liabilities€34M€5.03M€51M€48.9M€16.9M€44.4M€42.9M€78.1M€71.8M€55.6M€62.1M€24.3M
Total liabilities€53.4M€52.7M€83.3M€65.6M€68.4M€90.6M€131M€158M€165M€168M€141M€95.9M
Equity
Common stock & paid-in capital€143K€147K€168K€168K€223K€425K€629K€629K€633K€635K€785K€798K
Retained earnings-€37.6M-€54.1M-€81.8M-€108M-€144M-€52M-€283M-€353M-€439M-€529M-€738M-€865M
Accumulated other comprehensive income-€37.3M€7.12M€1K€24K€302K-€143M€112K€33K-€75K€484K€2.31M€1.77M
Shareholders' equity€17.9M€2.37M€25.9M€6.08M€7.19M€80.5M€196M€126M€40.6M-€48.3M€455M€366M
Debt
Total debt (incl. leases)€34M€31.8M€51.7M€48.9M€39.2M€34.7M€58M€113M€97.4M€84.6M€45.9M€1.21M
Net debt (debt - cash)€4.7M€27.5M-€9.05M€37.3M€12.2M-€79.7M-€194M-€109M-€46.9M€23.6M-€471M-€387M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in EUR.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02 · Amounts in EUR as reported; price and market cap in USD.